US Patent Family Members and Approved Drugs for Belgium Patent: 2022C502
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Belgium Patent: BE2022C502
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
